Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Detecting anti-donor antibodies by flow cytometry in pediatric kidney transplantation – is it necessary?

B Piątosa, K Siewiera, W Jarmużek, R Grenda

Ann Transplant 2009; 14(1): 38-38 :: ID: 880335

Abstract

Background: Immune response after allotransplantation depends on type of transplanted organ, mismatching degree, type of immunosuppression, as well as genetic predisposition of the recipient. Donor-specific antibodies resulting from pre-transplant immunization, as well as produced during response to donor antigens trigger cascade of many events leading to ultimate organ destruction. The purpose of this study was to verify whether we need to apply more sensitive than standard methods to detect antidonor antibodies before transplantation.
Material/Methods: Two hundred and thirteen paediatric patients were transplanted based on negative results of complement dependent cross-match (CDC). Three-color flow cytometric cross-match (FCXM) detecting IgG and IgM antibodies against T and B lymphocytes was performed on sera taken immediately prior to transplantation. Immunosuppression protocol was selected irrespective from results of FCXM. Biopsy-proven rejection rate, graft loss during first month after transplantation, serum creatinine level one and three months after transplantation, as well as median serum creatinine after longest observation period were used to evaluate renal function.
Results: Despite negative results of CDC, antibodies against donor lymphocytes detected by FCXM were found in 21.1% cases, with similar frequency against T and B lymphocytes. Lower relative number of patients with creatinine <1.5 mg/dl and more frequent biopsy-proven rejection were observed among patients with positive FCXM. Early graft loss occurred more frequently among patients with positive FCXM, IgM antibodies or anti-T lymphocyte IgG. Poor renal function one month after transplantation was observed more frequently among patients with antibodies against B lymphocytes or anti-donor lymphocyte IgMs, but no effect of positive FCXM on long-term kidney graft function was observed.
Conclusions: Positive FCXM is an important, although not unique, risk factor of rejection-induced graft loss early after transplantation. Significance of individual correlations can be reduced i.e. by individually tailored immunosuppression regimen.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Urinary Chemokines CXCL9 and CXCL10 Are Non-Invasive Biomarkers of Kidney Transplant Rejection

Ann Transplant In Press; DOI: 10.12659/AOT.944762  

Original article  

Risk Factors for Graft Failure After Penetrating Keratoplasty in Eastern China from 2018 to 2021

Ann Transplant In Press; DOI: 10.12659/AOT.945388  

Original article  

Predictive Model for Post-Transplant Renal Fibrosis Using Ultrasound Shear Wave Elastography

Ann Transplant In Press; DOI: 10.12659/AOT.945699  

Original article  

The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...

Ann Transplant In Press; DOI: 10.12659/AOT.945249  

Most Viewed Current Articles

05 Apr 2022 : Original article   12,974

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   10,077

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

12 Jan 2022 : Original article   9,421

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

15 Mar 2022 : Case report   7,180

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358